AAVIS Pharmaceuticals is one of the fastest growing pharmaceutical company covering a variety of therapeutic areas and dosage forms and few OTC products. Our business focuses on the development of Abbreviated New Drug Application (ANDA) which is based on generic products through our global network of development and manufacturing partners and has a robust emerging pipeline of niche pharmaceutical products.
Committed towards a healthier and happier world, we strive to provide our customers with high quality pharmaceuticals. Our products are manufactured in state-of-the-art GMP facilities using quality assurance techniques that meet regulatory standards.
Aavis would like to work as contract manufacturing organization maintaining world-class quality standards and delivering innovative products. Building solid partnerships with the clients plays a significant role in the development of our product pipeline and enables us to better serve people who rely on our products.